COMMUNIQUÉS West-GlobeNewswire

-
Evelo Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018 -
Chiesi Partnership with Durham Bulls Closes Season with $15,000 to Area Nonprofits
06/09/2018 -
Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference
06/09/2018 -
AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes
06/09/2018 -
Bespoke Extracts and Hip Hop Mega-Celebrity Soulja Boy to Collaborate on Development of Co-Branded CBD Product Line
06/09/2018 -
GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference
06/09/2018 -
Tower One September Update
06/09/2018 -
Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients
06/09/2018 -
Integrated Cannabis Company, Inc. Provides Corporate Update
06/09/2018 -
RedHill Biopharma Announces Advancement to Second Stage of Phase IIa Study with YELIVA® for Cholangiocarcinoma
06/09/2018 -
Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies
06/09/2018 -
Specialty Renal Products Announces $3 Million Series A Financing
06/09/2018 -
Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors
06/09/2018 -
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
06/09/2018 -
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City.
06/09/2018 -
Orphazyme to Present at BioCentury 25th Annual NewsMakers in the Biotech Industry
06/09/2018 -
UPDATE: Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada
06/09/2018 -
Intrommune Therapeutics Completes Pre-IND Meeting With FDA on INT301 for Peanut Allergy
06/09/2018 -
CMS Rating for Amedisys Home Health Improves for 11th Consecutive Quarter
06/09/2018
Pages